Call for Abstracts

Deadline for submissions:
August 15, 2024

The theme and focus of JFPS 2024 is Federal Pharmacy Professionals Lead the Way with Selfless Service to our Nation.

APhA is seeking abstracts for the JFPS 2024 poster program that represent pharmacy-focused scientific research and innovations in pharmacy practice relevant to federal pharmacists and pharmacy technicians.

Access Now 

Abstract Submission Process

Abstracts must be submitted by midnight ET on Thursday, August 15, 2024.

Click the link below and use your pharmacist.com username and password to access the JFPS 2024 online abstract submission form:

Access Now 

If you need to create an APhA account:

Go to https://www.pharmacist.com, click on Login, then Register. You do not have to be a member to create an account. Enter the email that you will use for notifications for JFPS 2024.

You may update your abstract until August 15. You must click the “Save and Finalize” button to finalize and submit your abstract. Upon submission, the submitter will receive a confirmation email with the details of the submission.

Abstract Authors

Abstract authors (up to 10) must be pharmacists or pharmacy technicians who are:

  • Uniformed members of the Public Health Services, Veterans Administration, or Department of Defense
  • Civilian pharmacists or technicians assigned to federal agencies.
  • Retired or reserve members of the Army, Navy, Air Force, Coast Guard, Veterans Administration, or Public Health Service

Financial Disclosures

Financial disclosures for all abstract authors will be collected during the online abstract submission process. Authors must disclose all financial relationships within the prior 24 months.

Abstract Categories

Submit abstracts to one of the following 3 categories:

  1. Contributed Research: Abstracts present the findings of original research on issues relevant to practicing pharmacists and pharmacy technicians. Research with patients requires IRB approval. (If research is not completed at the time of submission, select the “Project in Progress”* option.)
  2. Innovative Practice Report: Practitioners who have implemented a new idea or strategy for the delivery of patient care, or a creative application of existing techniques or services, are encouraged to share their innovation with colleagues. This includes process improvement projects that show improved patient outcomes. Ideas and practices that are new to the region, system, or practice setting may be considered. (If practices in this category do not have outcomes ready to report at the time of submission, select the “Project in Progress”* option.)
  3. Encore Presentation: Submissions to this category must meet all submission and evaluation criteria for original papers, with the exception that the paper has been previously presented at a local, state, or national meeting within 12 months of the submission deadline. Submission requires the original presentation citation.               

*Projects in Progress: Projects in progress must have been started and in the process of collecting data or in the process of implementing an innovative practice or process improvement.  Completed data or initial outcomes must be presented at JFPS 2024.

Abstract Topics

Submit abstracts to one of the following topics:

  1. Clinical Pharmacy
  2. Hospital Inpatient Services
  3. Pharmacy Operations
  4. Automation/Technology
  5. Readiness
  6. Other/Emerging Topics
Abstract Policies

Copyright

The Author(s) grant to APhA in perpetuity the exclusive right to print, publish, reproduce, lease, copy, and distribute (either in print or electronic form) the abstract. APhA will have the exclusive right to register the abstract in its own name and to obtain any renewals of the copyrights that may be permitted by law. The Author(s) warrant that the abstract is original; that the Author(s) own and have the right to convey all the rights herein conveyed to APhA; and that all content therein does not infringe any copyright, violate any property rights, or contain any scandalous or unlawful matter.

Indemnification

Author(s) shall defend, indemnify, and hold harmless APhA, its officers, directors, employees, and agents, against all liability or loss sustained as the result of a claim by a third-party based upon or arising out of any act or failure to act of Author(s) or the alleged breach by Author(s) of any representation, warranty, or agreement herein, including for any claims based upon any intellectual property violations. The warranties, representations and indemnities will survive the termination of this Agreement. Author(s) hereby release and discharge APhA, its officers, directors, employees, and agents, from any and all claims, demands, and causes of action that Author(s) may have against it by reason of its exercise of its rights hereunder including, without limitation, any claims based on the right of privacy, the right of publicity, copyright, libel, or slander.

Helpful Tips for Preparing Your Abstract
  • Be as specific, descriptive, and thorough as possible about project/study design, methods, data collection and analysis, results, and conclusion/implications
  • Use complete sentences
  • Include background information to justify why this program was created
  • Define time periods; include dates, where applicable
  • Describe patient population(s)
  • Define acronyms
  • Avoid the use of jargon
  • Check spelling and grammar
  • Do not identify facility or unit in the body of the abstract
Abstract Review and Notification

Abstracts submitted by Thursday, August 15, 2024 will be reviewed by the JFPS 2024 Educational Programming Committee. All abstracts are subjected to a double-blind peer review. Each abstract will be evaluated according to the following criteria:

  • Relevance – makes important contribution to federal pharmacy practice.
  • Originality – new, innovative approaches to move the pharmacy profession forward.
  • Clear statement of question(s) to be answered or objective(s) to be met.
  • Study/project design – project design clearly stated, appropriate to achieve objectives, and variables controlled. Setting and patient population described.
  • Methods and data collection process/analysis clearly descried. Source(s) of data, how it is being collected. Data analysis/evaluation procedures target project outcomes and support project objectives. Compare different strategies.
  • Results – findings are reported for each objective or research question. Include data in your results section. (Projects in Progress must report any initial findings.)
  • Implications of findings for pharmacy practice, policy theory, or further research are discussed and should focus on tangible or significant results. Describe how innovation is adaptable to other practice sites/settings. (Projects in Progress will describe potential implications.)
  • Conclusions are appropriately stated, based on results. (Projects in Progress will not include Conclusions on the abstract; however, conclusions should be included in the final poster presentation.)
  • Incomplete or poorly written abstracts will be rejected.
  • Revision is not offered for this program.
  • If you are a student or resident, work with your preceptor or faculty advisor to ensure that your abstract submission meets all criteria outlined.
Abstract Notification

In early September, APhA will notify abstract authors about the status of their abstract submission. Emails will only be sent to the email address of the submitter’s pharmacist.com account. 

If you have not received notification by September 13, 2024 contact APhA.

Accepted Abstracts and Poster Presentations

Accepted abstracts will be invited to present a poster at JFPS 2024 in both the onsite Meet the Researchers session and the virtual poster gallery. Poster presenters will upload a PDF of their poster and submit a 5-minute recording of their presentation for the virtual poster gallery.

Because the “Meet the Researchers” session offers CPE credit, the poster presentations must comply with the policy set forth by the Accreditation Council for Pharmacy Education (ACPE).:

The Accreditation Council for Pharmacy Education’s Standards for Integrity and Independence in Accredited Continuing Education require that all continuing pharmacy education providers “…must ensure that all decisions related to the planning, faculty selection, delivery, and evaluation of accredited education are made without any influence or involvement from the owners and employees of an ineligible company.” “Ineligible companies” are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Everyone in a position to control the content of an education activity is required to disclose “all their financial relationships within the prior 24 months.” Financial relationships are those in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, or other financial benefit. Financial benefits usually are associated with roles such as: employment, management position, independent contractor (including contracted research), consulting, speaking, teaching, membership on advisory committee or review panel, board membership, or any other activities in which remuneration is received or expected.

Ownership interests (e.g., ownership of stocks, stock options, or similar interests, excluding diversified mutual funds) also qualify as financial relationships.

How does this translate to your poster and use of logos?

  • Financial disclosures must be displayed on the poster
  • NO logos for pharmaceutical companies
  • OK to use logos for hospitals, universities, schools, health care networks
  • OK to use logos for community pharmacies (e.g., Walgreens, Kroger) IF they are also a provider of clinical care directly to patients

Poster Awards

To be eligible for the JFPS 2024 poster award program, the following requirements must be met:

  • The poster must be accepted for presentation.
  • Poster presenters must submit a PDF of their final poster and an accompanying audio recording.
  • The poster and accompanying audio recording must be displayed in the virtual poster gallery.

Posters are judged on Technical Merit, Originality, and Presentation.

Award plaques will be awarded to poster presenters for first place in each topic area, and one overall best of seminar. Special recognition ribbons will be awarded to the highest scoring poster that did not win its category. Awardees will be announced at the Closing General Session.

Abstract Publication

Accepted abstracts that are presented at JFPS 2024 will be e-published in a 2025 issue of the Journal of the American Pharmacists Association (JAPhA) at www.japha.org. APhA holds first right of refusal for material contained in abstracts when submitted for publication. Full manuscripts that expand on the abstracts should be submitted for publication in an APhA publication, usually JAPhA at www.japha.org.  Encore presentations are not published in their entirety; only the title, authors, and original citation will appear.

More Information

For more information, please contact Ellyn Terry at eterry@aphanet.org.